Infliximab, etanercept, adalimumab (DrugBank: Etanercept, Adalimumab, Infliximab)
15 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
15 | 封入体筋炎 | 0 |
28 | 全身性アミロイドーシス | 0 |
35 | 天疱瘡 | 0 |
38 | スティーヴンス・ジョンソン症候群 | 0 |
39 | 中毒性表皮壊死症 | 0 |
46 | 悪性関節リウマチ | 1 |
50 | 皮膚筋炎/多発性筋炎 | 0 |
53 | シェーグレン症候群 | 0 |
56 | ベーチェット病 | 0 |
60 | 再生不良性貧血 | 0 |
85 | 特発性間質性肺炎 | 0 |
228 | 閉塞性細気管支炎 | 0 |
271 | 強直性脊椎炎 | 0 |
285 | ファンコニ貧血 | 0 |
298 | 遺伝性膵炎 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01000441 (ClinicalTrials.gov) | December 2009 | 22/10/2009 | Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis | Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis | Rheumatoid Arthritis | Drug: infliximab, etanercept, adalimumab;Drug: abatacept, rituximab or tocilizumab | University Hospital, Strasbourg, France | NULL | Recruiting | 18 Years | N/A | Both | 300 | Phase 4 | France;Monaco |